Review Article

Neuroimaging Measures as Endophenotypes in Alzheimer's Disease

Table 1

Top AD risk genes.

GeneProteinPopulationPolymorphism

1APOE_e2/3/4apolipoprotein EallAPOE_e2/3/4*
2CLUclusterinallrs11136000*
3EXOC3L2exocyst complex component 3-like 2allrs597668
4BIN1bridging integrator 1allrs744373
5PICALMphosphatidylinositol binding clathrin assembly proteinallrs541458*
6SORL1sortilin-related receptorAsianrs2282649*
7GWA_14q32.13unknownallrs11622883
8TNK1tyrosine kinase non-receptor, 1allrs1554948
9ACEangiotensin I converting enzyme (peptidyl-dipeptidase A) 1Caucasianrs1800764
10IL8interleukin 8allrs4073
11LDLRlow density lipoprotein receptorallrs5930
12CST3cystatin CCaucasianrs1064039*
13CR1complement component (3b/4b) receptor 1 (Knops blood group)allrs6656401
14hCG2039140unknownallrs1903908
15CHRNB2cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal)allrs4845378
16SORCS1sortilin-related VPS10 domain containing receptor 1allrs600879
17TNF tumor necrosis factor alphaAsianrs4647198
18CCR2chemokine (C-C motif) receptor 2Caucasianrs1799864

Genes listed represent those most highly associated with AD per alzgene.org [9] as of August 22, 2010. Only those with high or moderate epidemiological evidence are included above. Grading was based on HuGENet (Human Genome Epidemiology Network) interim criteria for the assessment of cumulative evidence of genetic associations [132].
*At least one neuroimaging study has investigated the effects of this polymorphism in the brain.